πŸ‡ΊπŸ‡Έ FDA
Patent

US 8501746

Organic compounds

granted A61KA61K31/4436A61K31/4439

Quick answer

US patent 8501746 (Organic compounds) held by Xenon Pharmaceuticals Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4436, A61K31/4439, A61K31/444, A61K31/497